Fatal sickle cell crisis after granulocyte colony-stimulating factor administration

被引：136

作者：

Adler, BK ^{[1
]}

Salzman, DE ^{[1
]}

Carabasi, MH ^{[1
]}

Vaughan, WP ^{[1
]}

Reddy, VVB ^{[1
]}

Prchal, JT ^{[1
]}

机构：

[1] Univ Alabama, Div Hematol Oncol, Birmingham, AL 35294 USA

来源：

BLOOD | 2001年 / 97卷 / 10期

关键词：

D O I：

10.1182/blood.V97.10.3313

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：3313 / 3314

页数：2

相关论文

共 7 条

[1] Abboud M, 1998, LANCET, V351, P959
[2] Duits AJ, 1998, EUR J HAEMATOL, V61, P302
[3] Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64
Fadlon, E
Vordermeier, S
Pearson, TC
Mire-Sluis, AR
Dumonde, DC
Phillips, J
Fishlock, K
Brown, KA
[J]. BLOOD, 1998, 91 (01) : 266 - 274
[4] Plasma endothelin-1, cytokine, and prostaglandin E2 levels in sickle cell disease and acute vaso-occlusive sickle crisis
Graido-Gonzalez, E
Doherty, JC
Bergreen, EW
Organ, G
Telfer, M
McMillen, MA
[J]. BLOOD, 1998, 92 (07) : 2551 - 2555
[5] Hoglund M, 1997, EUR J HAEMATOL, V58, P195
[6] MOLGRAMOSTIM TO TREAT SS-SICKLE CELL LEG ULCERS
PIETERS, RC
ROJER, RA
SALEH, AW
SALEH, AEC
DUITS, AJ
[J]. LANCET, 1995, 345 (8948): : 528 - 528
[7] MORTALITY IN SICKLE-CELL DISEASE - LIFE EXPECTANCY AND RISK-FACTORS FOR EARLY DEATH
PLATT, OS
BRAMBILLA, DJ
ROSSE, WF
MILNER, PF
CASTRO, O
STEINBERG, MH
KLUG, PP
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1994, 330 (23) : 1639 - 1644